Ph.D., VP Product Discovery, Bellicum Pharmaceuticals
Dr. Foster is Vice President of Product Discovery at Bellicum Pharmaceuticals. He leads the CAR and engineered TCR T cell programs that incorporate novel molecular switches to control T cell behavior in vivo using small molecule ligands. Prior to joining Bellicum in 2012, he was an Assistant Professor at Baylor College of Medicine at the Center for Cell and Gene Therapy, where he led a group researching adoptive T cell therapies, cancer vaccines and nanotherapeutics. He received his B.A. in Biology from the University of Puget Sound and his Ph.D. in Chemical Engineering from the University of Sydney.
Presentation Title and Company Description
Immunotherapy Showcase: Molecular Switch Technology for Cell Therapies
Bellicum is developing controllable cell therapies for the treatment of cancer and heritable blood disorders. Our products incorporate molecular switches designed to control the therapeutic activity of the cells once inside the body enabling safer, more effective therapies.